Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 60 versus DEXTROSE 60 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 60 versus DEXTROSE 60 IN PLASTIC CONTAINER.
DEXTROSE 60% vs DEXTROSE 60% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a monosaccharide that provides a source of calories and hydration. It increases blood glucose levels and is metabolized to carbon dioxide and water, yielding energy.
Dextrose 60% is a hypertonic solution that increases blood glucose levels, providing a source of calories and fluid. It acts as an osmotic diuretic at high concentrations, drawing water from intracellular to extracellular spaces.
Intravenous: For hypoglycemia, 0.5-1 g/kg (10-25 g) as 50% solution; for hyperkalemia, 25 g dextrose with 10 units regular insulin IV. For parenteral nutrition, variable per metabolic needs. Infusion rate not to exceed 0.5 g/kg/h.
250 mL of 60% dextrose (150 g) intravenously over 2 hours for hypoglycemia; for parenteral nutrition, dosage individualized based on caloric requirements and glucose tolerance.
None Documented
None Documented
5–10 minutes (for glucose itself; dextrose is glucose). Clinically, rapid distribution and metabolism.
Approximately 1.5-2.5 hours for exogenous glucose; clinically relevant in monitoring glucose infusion rates in critically ill patients.
Renal: 100% (unchanged) if renal threshold not exceeded; otherwise, glucosuria. Biliary/fecal: negligible.
Renal: essentially 100% as CO2 and water; negligible unchanged glucose under normal conditions; in hyperglycemia, small amounts (<5%) excreted unchanged in urine when renal threshold exceeded.
Category C
Category C
Intravenous Hypertonic Dextrose Solution
Intravenous Hypertonic Dextrose Solution